诊断学理论与实践 ›› 2026, Vol. 25 ›› Issue (03): 346-353.doi: 10.16150/j.1671-2870.2026.03.011
收稿日期:2025-10-09
修回日期:2026-03-06
接受日期:2026-03-06
出版日期:2026-06-25
发布日期:2026-06-27
通讯作者:
章安迪 E-mail:xlyouxiangzad@sina.com作者简介:第一联系人: 叶远征负责课题设计、实验方案制定、论文撰写与修改,对研究工作的整体构思与学术内容负责。付晓晓主要完成细胞实验操作,参与数据采集与整理。门莉负责基因与蛋白表达检测及相关数据分析。马前程完成流式细胞术、钙稳态指标等测定。章安迪提供技术指导,参与课题思路讨论、论文审阅与学术修改。范平参与数据统计分析及图表制作,协助论文初稿整理与格式规范。
基金资助:
YE Yuanzheng1, FU Xiaoxiao2, MEN Li1, MA Qiancheng3, ZHANG Andi4(
)
Received:2025-10-09
Revised:2026-03-06
Accepted:2026-03-06
Published:2026-06-25
Online:2026-06-27
摘要:
目的:探讨低浓度咖啡因对兰尼碱受体2(ryanodine receptor 2, RyR2)敲低的大鼠心肌细胞钙稳态及凋亡的影响。方法:采用SPF级新生SD大鼠,分离提取新生大鼠心室肌细胞(newborn rat ventricular myocytes, NRVMs),分别将合成的转染RyR2小干扰RNA(small interfering RNA, siRNA)和阴性对照(negative control,NC)转染至NRVMs细胞,并将细胞分为NC组(转染siRNA NC)、siRYR2组(转染RyR2 siRNA)、NC+咖啡因组(转染siRNA后,添加0.2 mmol/L咖啡因),及siRYR2+咖啡因组(转染RyR2 siRNA后,添加0.2 mmol/L咖啡因)4组。采用实时荧光定量聚合酶链反应(quantitative real-time polymerase chain reaction,qRT-PCR)和蛋白印迹法检测RyR2的mRNA和蛋白表达量,用流式细胞仪检测细胞凋亡和钙离子,用共聚焦钙离子成像检测游离钙离子浓度。对NC组、siRYR2、NC+咖啡因组、siRYR2+咖啡因组的数据进行单因素方差分析。结果:与NC组相比,siRyR2组的RyR2 mRNA和蛋白相对表达量显著降低(mRNA:0.41±0.04比1.00±0.09,P=0.000 3;蛋白:0.34±0.04比0.72±0.02,P=0.000 1),钙离子浓度显著降低(流式细胞仪:0.80±0.02比1.00±0.02,P<0.000 1;共聚焦钙离子成像仪:61.08%±0.75%比100.00%±2.33%,P<0.000 1),细胞凋亡率显著增加(9.21%±0.07%比4.19%±0.07%,P<0.000 1),而NC+咖啡因组的RyR2 mRNA和蛋白表达量显著增加(mRNA:1.27±0.15比1.00±0.09,P=0.033 6;蛋白:0.92±0.10比0.72±0.02,P=0.006 5),钙离子浓度显著增加(流式细胞仪:1.33±0.04比1.00±0.02,P<0.000 1;共聚焦钙离子成像仪:116.21%±1.51%比100.00%±2.33%,P=0.000 6),细胞凋亡率显著降低(2.97%±0.13%比4.19%±0.07%,P<0.000 1)。与siRyR2组相比,si-RyR2+咖啡因组的RyR2 mRNA和蛋白相对表达量显著增加(mRNA:0.67±0.08比0.41±0.04,P=0.044 7;蛋白:0.54±0.01比0.34±0.04,P=0.009 1),钙离子浓度显著增加(流式细胞仪:0.87±0.02比0.80±0.02,P=0.026 3;共聚焦钙离子成像仪:79.14%±5.02%比61.08%±0.75%,P=0.000 3),细胞凋亡率显著降低(7.59%±0.10%比9.21%±0.07%,P<0.000 1)。与NC+咖啡因组相比,si-RyR2+咖啡因组的RYR2 mRNA和蛋白表达量显著降低(mRNA:0.67±0.08比1.27±0.15,P=0.000 2;蛋白:0.54±0.01比0.92±0.10,P<0.000 1),钙离子浓度显著降低(流式细胞仪:0.87±0.02比1.33±0.04,P<0.000 1;共聚焦钙离子成像仪:79.14%±5.02%比116.21%±1.51%,P<0.000 1),细胞凋亡率显著增加(7.59%±0.10%比2.97%±0.13%,P<0.000 1)。结论:低浓度咖啡因可以通过上调心肌细胞RyR2,促进钙离子释放,恢复钙稳态,减少细胞凋亡。这种咖啡因与RyR2的相互作用机制,可为开发由RyR2表达降低引起的心律失常等心脏疾病的治疗药物提供参考依据。
中图分类号:
叶远征, 付晓晓, 门莉, 马前程, 章安迪. RyR2敲低引起心肌细胞钙稳态失衡和凋亡可被咖啡因缓解[J]. 诊断学理论与实践, 2026, 25(03): 346-353.
YE Yuanzheng, FU Xiaoxiao, MEN Li, MA Qiancheng, ZHANG Andi. Caffeine-mediated alleviation of imbalance of calcium homeostasis and apoptosis in cardiomyocytes caused by RyR2 knockdown[J]. Journal of Diagnostics Concepts & Practice, 2026, 25(03): 346-353.
| [1] | SECCO I, GIACCA M. Regulation of endogenous cardiomyocyte proliferation: The known unknowns[J]. J Mol Cell Cardiol, 2023,179:80-89. |
| [2] |
KAUR S, BHATTI G K, KHULLAR N, et al. Calcium signalling and organelle crosstalk in cardiovascular disease: An interplay of cardiac cell death pathways[J]. Mol Biol Rep, 2025, 52(1):907.
doi: 10.1007/s11033-025-10974-6 pmid: 40956539 |
| [3] |
REDEL-TRAUB G, MARX S O, MARKS A R. Targeting calcium regulation for heart failure and arrhythmia therapeutics: A critical review[J]. Circulation, 2025, 152(13):957-970.
doi: 10.1161/CIRCULATIONAHA.125.075150 URL |
| [4] | XING Y, CUI T, SUN F. A novel RyR2 mutation associated with co-morbid catecholaminergic polymorphic ventricular tachycardia (CPVT) and benign epilepsy with centrotemporal spikes (BECTS)[J]. J Electrocardiol, 2024,84:75-80. |
| [5] | 丁宣尹, 雷迁. 兰尼碱受体2在心脏疾病中的研究现状[J]. 实用医院临床杂志, 2024, 21(3):181-184. |
| DING X Y, LEI Q. Current status of RyR2 research in heart disease[J]. Pract J Clin Med, 2024, 21(3):181-184. | |
| [6] | DO T Q, KNOLLMANN B C. Inhibitors of intracellular RyR2 calcium release channels as therapeutic agents in arrhythmogenic heart diseases[J]. Annu Rev Pharmacol Toxicol, 2025,65:443-463. |
| [7] | FUJII S, KOBAYASHI S, CHANG Y, et al. RyR2-targe-ting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure[J]. J Mol Cell Cardiol, 2023,178:36-50. |
| [8] | KOBAYASHI S, YAMAMOTO T, YANO M. RyR2-stabilization therapy with dantrolene against left ventricular remodeling and lethal arrhythmia in heart failure[J]. J Mol Cell Cardiol, 2023,182:25-27. |
| [9] | KAPLAN A D, BOYMAN L, WARD C W, et al. Ryanodine receptor stabilization therapy suppresses Ca2+- based arrhythmias in a novel model of metabolic HFpEF[J]. J Mol Cell Cardiol, 2024,195:68-72. |
| [10] |
MARKS A R. Targeting ryanodine receptors to treat human diseases[J]. J Clin Investig, 2023, 133(2):e162891.
doi: 10.1172/JCI162891 URL |
| [11] |
EHRLICH B E, KAFTAN E, BEZPROZVANNAYA S, et al. The pharmacology of intracellular Ca2+-release channels[J]. Trends Pharmacol Sci, 1994, 15(5):145-149.
doi: 10.1016/0165-6147(94)90074-4 URL |
| [12] |
王伟, 李莎, 张梦丹, 等. liguzinediol基于肌浆网钙泵促进钙释放发挥正性肌力作用[J]. 中国药理学与毒理学杂志, 2016, 30(3):197-202.
doi: 10.3867/j.issn.1000-3002.2016.03.003 |
| WANG W, LI S, ZHANG M D, et al. Liguzinediol exerts positive inotropic effect by enhancing Ca 2+release from sarcoplasmic reticulum mediated by sarcoplasmic reticulum Ca2+ATPase[J]. Chin J Pharmacol Toxicol, 2016, 30(3):197-202. | |
| [13] | 李博, 吴慧颖, 朴虎林, 等. 新生大鼠心肌细胞原代培养方法的改良[J]. 中国实验诊断学, 2012, 16(2):200-203. |
| LI B, WU H Y, PIAO H L, et al. The primary culture of neonatal rat cardiac cells[J]. Chin J Lab Diagn, 2012, 16(2):200-203. | |
| [14] |
GAIDAI O, CAO Y, LOGINOV S. Global cardiovascular diseases death rate prediction[J]. Curr Probl Cardiol, 2023, 48(5):101622.
doi: 10.1016/j.cpcardiol.2023.101622 URL |
| [15] |
CALDWELL J L, CLARKE J D, SMITH C E R, et al. Resto-ring atrial T-tubules augments systolic Ca upon recovery from heart failure[J]. Circ Res, 2024, 135(7):739-754.
doi: 10.1161/CIRCRESAHA.124.324601 URL |
| [16] |
BAKER A J, LI O Y, JEŽEK F, et al. Ca2+ increases cardiac muscle viscoelasticity independent of active force development[J]. Biophys J, 2025, 124(16):2698-2707.
doi: 10.1016/j.bpj.2025.07.009 URL |
| [17] | 秦京京, 武瑞, 韩庆烽. 基于颈动脉粥样硬化标志物的高校职工心血管疾病风险预测模型比较[J]. 中国临床研究, 2026, 39(2):252-256. |
| QIN J J, WU D, HANG Q F. Comparison of cardiovascular disease risk prediction models in university staff based on carotid atherosclerosis biomarker[J]. Chin J Clin Res, 2026, 39(2):252-256. | |
| [18] |
LV T, LI S, LI Q, et al. The role of RyR2 mutations in congenital heart diseases: Insights into cardiac electrophysiological mechanisms[J]. Cardiovasc Electrophysiol, 2025, 36(3):683-692.
doi: 10.1111/jce.v36.3 URL |
| [19] | STARNES L, HALL A, ETAL D, et al. RYR2 deficient human model identifies calcium handling and metabolic dysfunction impacting pharmacological responses[J]. Front Cardiovasc Med, 2024,11:1357315. |
| [20] |
DEWLAND T A, VAN DAM R M, MARCUS G M. Coffee and cardiovascular disease[J]. Eur Heart J, 2025, 46(36):3546-3554.
doi: 10.1093/eurheartj/ehaf421 pmid: 40626862 |
| [21] | 王明, 王春丽, 张永正. 心肌细胞凋亡信号通路在心肌梗死中的作用及其研究进展[J]. 安徽医学, 2026, 47(5):648-652. |
| WANG M, WANG C L, ZHANG Y Z. The role and research progress of cardiomyocyte apoptosis signaling pathway in myocardial infarction[J]. Anhui Med, 2026, 47(5):648-652. | |
| [22] | 邓洁, 刘晓明, 卢微. 中青年营养状况与冠心病的关系[J]. 中华全科医学, 2025, 23(11):1834-1837. |
| DENG J, LIU X M, LU W. The relationship between nutritional status and coronary atherosclerotic heart disease in young and middle-aged people[J]. Chin J Gen Pract, 2025, 23(11):1834-1837. | |
| [23] |
CAMPAGNA R, VIGNINI A. The role of xenobiotic caffeine on cardiovascular health: Promises and challenges[J]. JoX, 2025, 15(2):51.
doi: 10.3390/jox15020051 URL |
| [24] |
MÜLLER C E, DALY J W. Stimulation of calcium release by caffeine analogs in pheochromocytoma cells[J]. Biochem Pharmacol, 1993, 46(10):1825-1829.
pmid: 8250969 |
| [25] | SHKRYL V M. The spatio-temporal properties of calcium transients in hippocampal pyramidal neurons in vitro[J]. Front Cell Neurosci, 2022,16:1054950. |
| [26] | CHOI K J, JEON W Y, LEE M Y, et al. Histamine-induced cytosolic calcium mobilization in human bronchial smooth muscle cells[J]. J Smooth Muscle Res, 2025,61:29-42. |
| [27] | LEE C, DENNETT A M, PINSON J A, et al. Caffeine consumed prior to cardiac stress testing may affect diagnostic accuracy of nuclear medicine myocardial imaging of myocardial ischemia: A systematic review and meta-analysis[J]. J Med Imag Radiat Sci, 2024, 55(1):134-145. |
| [28] | LIU B, ZHU X, ZHOU Q, et al. Activating ryanodine receptor improves isoflurane-induced cognitive dysfunction[J]. Brain Res Bull, 2023,204:110790. |
| [1] | 王梦真, 鲍守钰, 刘鹏, 严福华, 杨文洁. 光子计数CT在心血管疾病中的应用[J]. 诊断学理论与实践, 2025, 24(02): 125-134. |
| [2] | 张珂, 张唯一, 孙海天, 曹铭峰, 张新焕. 细胞失巢相关基因PDK4与2型糖尿病发病相关——基于生物信息的研究[J]. 诊断学理论与实践, 2025, 24(01): 27-34. |
| [3] | 施仲伟. 回眸过去30年全球和中国的心血管疾病负担及其危险因素——1990年至2019年全球心血管疾病负担及其危险因素报告解读[J]. 诊断学理论与实践, 2021, 20(04): 349-355. |
| [4] | 查晴, 于晨溪, 刘亚, 杨玲, 叶佳雯, 刘艳. miR-16在冠状动脉粥样硬化斑块进展中的作用及初步机制研究[J]. 诊断学理论与实践, 2021, 20(01): 82-87. |
| [5] | 吴歆, 耿旭强, 徐沪济. 多基因风险评分在复杂性状疾病中的应用进展[J]. 诊断学理论与实践, 2020, 19(05): 540-543. |
| [6] | 倪瀚文, 吴立群. 外泌体在心肌缺血及房颤诊治中的应用前景研究进展[J]. 诊断学理论与实践, 2020, 19(02): 199-202. |
| [7] | 陈瑶瑶, 顾爱华. 氧化三甲胺与心血管疾病关系的研究进展[J]. 诊断学理论与实践, 2019, 18(2): 237-240. |
| [8] | 朱庆锋, 胡晓丽, 朱坚轶, 郎雯竞, 钟济华, 陈芳源. ASP2215联合SAHA对FLT3-ITD突变细胞株体外协同机制研究[J]. 诊断学理论与实践, 2018, 17(05): 538-546. |
| [9] | 郑鹏茜, 刘立根,. 血清可溶性肿瘤坏死因子相关凋亡诱导配体检测的临床意义[J]. 诊断学理论与实践, 2015, 14(05): 479-482. |
| [10] | 齐研, 贾慧英,. 丙戊酸盐对甲状腺髓样癌TT细胞的影响[J]. 诊断学理论与实践, 2015, 14(03): 248-251. |
| [11] | 郭沛, 贾培敏, 童建华, 李军民,. 阿糖胞苷联合冬凌草甲素诱导U937细胞株凋亡的初步研究[J]. 诊断学理论与实践, 2014, 13(06): 570-574. |
| [12] | 熊杰, 朱伟嵘, 钱樱, 赵维莅,. 黄芩苷诱导T细胞淋巴瘤凋亡的初步研究[J]. 诊断学理论与实践, 2014, 13(04): 398-402. |
| [13] | 华沙, 赵建荣,. 载脂蛋白A5调节三酰甘油代谢及其对心血管疾病影响[J]. 诊断学理论与实践, 2014, 13(03): 336-340. |
| [14] | 陈芳源, 张旻玥, 蔡佳翌, 沈莉菁, 钟济华, 曹兰芳,. 黄酮联合阿霉素协同诱导HL60/ADR细胞凋亡机制的研究[J]. 诊断学理论与实践, 2014, 13(02): 159-165. |
| [15] | 周凌云, 陈芳源, 沈莉菁, 万海霞, 钟济华, 蔡佳翌,. 三氧化二砷对白血病细胞EVI-1基因作用的研究[J]. 诊断学理论与实践, 2014, 13(01): 54-60. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||